The Nature of the Anticoagulant Effect of Heparin, Protamine, Polybrene and Toluidine Blue

References

• Archer R. K., Flute P. Heparin aid thromboplastin generation in the horse. Nature 1953; 183: 235
   Google Scholar
• Astrup T., Darling S. Antithrombin und Heparin. Naturwissenschaften 1941; 29: 300
   Google Scholar
• Mason M. F., Hawley G., Darling S. Measurements and properties of antithrombin Aota physiol scand. 1942; 4: 293
   Google Scholar
• Mason M. F., Hawley G., Ollendorff P. Estimation of thromboplastin activation in plasma. Scand. J. clin. Lab. Invest. 1961; 13: 377
   Google Scholar
• Biggs R., Douglas A. S., MacFarlane R. G. The actian of thromboplastic substances. J.' Physiol. (Land.) 1953; 122: 554
   PubMedGoogle Scholar
• Brinkhous K. M., Smith H. P., Warner E. D., Seegers W. H. The inhibition of blood clotting: An unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin in thrombin Am. J. Physiol. 1939; 125: 683
   Google Scholar
• Chargaff E., Ziff M., Cohen S. S. Studies on the chemistry of blood coagulation. The reaction between heparin and the thromboplastic factor. J., biol. Chem. 1940; 136: 257
   Google Scholar
• Dougles A. S. The action of heparin in the prevention of prothrombin conversion. J. clin. Invest. 1956; 35: 533
   Google Scholar
• Ferguson J. H. The action of heparin, serum albumin (crystalline) and salmine on blood-clotting mechanism (in vitro). Am. J. Physiol. 1940; 130: 759
   Google Scholar
• Mason M. F., Hawley G., Glazko A. J. Heparin and natural antiprothrombin in relation to activation and “assay” of prothrombin. Ibid. 1941; 134: 47
   Google Scholar
• Fischer A. Die Bindung von Heparin an Etweiss. Biochem. Z. 1935; 278: 133
   Google Scholar
• Mason M. F., Hawley G., Astrup T. Stöchiometrische Bindungsver-hältnisse zwischen Haparin und Gerinnuungs-stoff. Ibid. 1935; 278: 326
   Google Scholar
• Fuch S. H. J. Wichtige methodische Einzelheiten bei Blutgerimnungsuntersuchungen sowie eine Isoliesungsmethodik des physiologilschen gerinnungshememenden Faktors (Antiprohom-bin) aus Blut und Gewebe. Ibid. 1930; 222: 470
   Google Scholar
• Godal H. C. The interaction of protamine with human fibrinogen and the significance of this interaction for the coagulation of fibrinogen. Scand. J. clin. Lab. Invest. 1960; 12: 433
   PubMed Web of Science ®Google Scholar
• Burstein M., Guinand A. A comparison of two heparin-neutralizing agents: protamine and polybrene. Ibid. 1960; 12: 446
   Google Scholar
• Gormsen J. Koagulationsproblemer ved akut coronarthrombose. Thesis. København. 1957
   Google Scholar
• Greig K. B. W. Christmas-factor (factor- IX) deficiency produced by concurrent administration of heparin with coumarin drugs. Lancet ii 1959; 25
   Google Scholar
• Grossman B. J., Astrup T. In vitro effects of haparin and chondroitin sulfuric acid B on the generation of thrombin scand. J. clin Lab. in vest. 1961; 13: 79
   Google Scholar
• Hougie C. Anticoagulant action of protamine sulphate. Proc. Soc. exp. Biol. (N.Y.) 1958; 98: 130
   PubMed Web of Science ®Google Scholar
• Howell W. H. The preparation and properties of thrombin, together with observations on antithrombin and prothrombin Am. J. Physiol. 1910; 26: 453
   Google Scholar
• Mason M. F., Hawley G., Holt E. Two new factors in blood coagulation—heparin and pro-antithrombin. Ibid. 1918/19; 47: 328
   Google Scholar
• MacMillan R. L., Brown K. W. G. Heparin and thromboplastin. JLab. olio. Med. 1954; 44: 378
   PubMedGoogle Scholar
• Magnusson S., Nilson J. M. Heparin mono-sulphuric aciid β-heparin and dog mast cell tumour heparin in different clotting systems. Acta physiol scand. 1957; 39: 36
   Google Scholar
• Mellanby J. Hoparin and blood coagulation. Proc. roy. Sac. B 1934; 116: 1
   Google Scholar
• O'Brien J. R. Heparin and Christmas factor. Nature 1958; 181: 1801
   Google Scholar
• Burstein M., Guinand A. The effect of heparin on the early stages of blood coagulation. J. clin. Path. 1960; 13: 93
   Google Scholar
• Ollendorff P. Improvement in the thrombin generation test. Thromb. Diath. haemorrh. 1940; 4: 264
   Google Scholar
• Burstein M., Guinand A. Christmas faktor mangel under behaudling med dicumarol og heparin. Ugesler. Laeg. 1960; 122: 1680
   Google Scholar
• Owren P. A., Aas A. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scald J. clin Lab. Invest. 1951; 3: 201
   PubMed Web of Science ®Google Scholar
• Perkins H. A., Acra D. J., Rolfs M. M. Duration of coagulation abnormalities following in vivo neutralization of heparin by protamine and polybrene. Jclin. Invest. 1960; 39: 1016
   Google Scholar
• Portman F., Holden W. D. Protamine (Salmine) sulphate, heparin and blood coagulation. Ibid 1949; 28: 1451
   Google Scholar
• Quick A. J. On the action of heparin and its relation to thromboplastin. Am. J. Physiol. 1936; 115: 317
   Google Scholar
• Burstein M., Guinand A. The normal antithrombin of the blood and its relation to heparin. Ibid. 1938; 123: 712
   Google Scholar
• Regan E. E., Sarelis A., Shanberge J. N. Heparin, protamine & thromboplastin generation. Fed. Proc. 1959; 18: 501
   Google Scholar
• Shanberge J. N. Action of protamine on thromboplastin generation. Ibid. 1958; 17: 456
   Google Scholar
• Sarelis A., Regain E. E. Effect of heparin on thromboplastin generation. Ibid. 1959a; 18: 505
   Google Scholar
• Carlston A., Hallgren B., Jagenburg R., Svanborg A., Werkö L. The effect of heparin on plasma thromboplastin formation. J. Lab. clin. Med. 1959; 54: 501
   Google Scholar
• Tanturi C. A., Wetzel M. C. Studies upon the relation between plasma antithrombin on prothrombin time Am. J. Med. Sci. 1949; 217: 410
   Google Scholar
• Telford J., Keats A. S. Relative anti-heparin potency of polybrene and protamine in patients undergoing extracorporeal circulation. Fed. Proc. 1959; 18: 451
   Google Scholar
• Tocantins L. M. Cephalin, protamine and the anti-thromboplastic activity of normal and hemophilic plasmas. Proc. Soc. exp. Biol. (N.Y.) 1913; 54: 94
   Google Scholar
• Waldschmidt-Leitz E, Stadler P., Steiger-Nafdt F. Über Blutgerinnung. Hemmung und Beschleuningung. Z. physiol. Chem. (Hoppe-Seylem Z. physiol. Chem.) 1929; 183: 39
   Google Scholar
• Volkent M. Studies on the antithrombin content of the blood and b relation to heparin. Acta physiol. scand. 1942; 5
   Google Scholar